Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
NCT05264727Phase 4Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- May 2023
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of clinisol in type 2 diabetes mellitus (T2DM), obesity, sponsored by Mayo Clinic. Started May 2023; status: active, not recruiting.
02
Drugs
clinisol
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT05264727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05264727.